http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 11 Oct 2024 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html <p><strong>ORLANDO, FL / ACCESSWIRE / October 11, 2024 / </strong>RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip <i>Small Stocks, Big Money™</i> show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.</p><p><strong>Access the interviews in their entirety at:</strong></p><ul style="list-style-type:disc;"><li><p>BioVie: <a rel="nofollow" href="https://pr.report/3fzo">https://www.redchip.com/assets/access/bivi_access</a></p></li><li><p>Genetic Technologies: <a rel="nofollow" href="https://pr.report/3fzp">https://www.redchip.com/assets/access/gene_access</a></p></li></ul><p>In an exclusive interview, Cuong Do, President and CEO of BioVie, who will share insight into the Company's pipeline of late-stage http://www.streetinsider.com/Press+Releases/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html Fri, 11 Oct 2024 09:00:00 -0400 BIVI GENE http://www.streetinsider.com/Press+Releases/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html <p><strong>ORLANDO, FL / ACCESSWIRE / October 11, 2024 / </strong>RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip <i>Small Stocks, Big Money™</i> show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.</p><p><strong>Access the interviews in their entirety at:</strong></p><ul style="list-style-type:disc;"><li><p>BioVie: <a rel="nofollow" href="https://pr.report/3fzo">https://www.redchip.com/assets/access/bivi_access</a></p></li><li><p>Genetic Technologies: <a rel="nofollow" href="https://pr.report/3fzp">https://www.redchip.com/assets/access/gene_access</a></p></li></ul><p>In an exclusive interview, Cuong Do, President and CEO of BioVie, who will share insight into the Company's pipeline of late-stage http://www.streetinsider.com/Press+Releases/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html Fri, 11 Oct 2024 09:00:00 -0400 BIVI GENE http://www.streetinsider.com/Accesswire/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html <p><strong>ORLANDO, FL / ACCESSWIRE / October 11, 2024 / </strong>RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip <i>Small Stocks, Big Money™</i> show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.</p><p><strong>Access the interviews in their entirety at:</strong></p><ul style="list-style-type:disc;"><li><p>BioVie: <a rel="nofollow" href="https://pr.report/3fzo">https://www.redchip.com/assets/access/bivi_access</a></p></li><li><p>Genetic Technologies: <a rel="nofollow" href="https://pr.report/3fzp">https://www.redchip.com/assets/access/gene_access</a></p></li></ul><p>In an exclusive interview, Cuong Do, President and CEO of BioVie, who will share insight into the Company's pipeline of late-stage http://www.streetinsider.com/Accesswire/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html Fri, 11 Oct 2024 09:00:00 -0400 BIVI GENE http://www.streetinsider.com/Accesswire/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html <p><strong>ORLANDO, FL / ACCESSWIRE / October 11, 2024 / </strong>RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip <i>Small Stocks, Big Money™</i> show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.</p><p><strong>Access the interviews in their entirety at:</strong></p><ul style="list-style-type:disc;"><li><p>BioVie: <a rel="nofollow" href="https://pr.report/3fzo">https://www.redchip.com/assets/access/bivi_access</a></p></li><li><p>Genetic Technologies: <a rel="nofollow" href="https://pr.report/3fzp">https://www.redchip.com/assets/access/gene_access</a></p></li></ul><p>In an exclusive interview, Cuong Do, President and CEO of BioVie, who will share insight into the Company's pipeline of late-stage http://www.streetinsider.com/Accesswire/BioVie+and+Genetic+Technologies+Interviews+to+Air+on+the+RedChip+Small+Stocks%2C+Big+Money%28TM%29+Show+on+Bloomberg+TV/23828215.html Fri, 11 Oct 2024 09:00:00 -0400 BIVI GENE http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html <p align="left">MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease, along with progress on its recent move to a capital light model.</p> <p>Genetic Technologies’ EasyDNA platform has over http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+October+2/23749456.html Mon, 23 Sep 2024 08:30:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Press+Releases/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html <p align="left">MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on August 15, 2024, at 4:15 p.m. ET.<br/></p> <p>The exclusive event, hosted by RedChip Companies, will feature some of Genetic Technologies Senior Executives, who will share insight into the Company’s portfolio of genomics-based tests targeting health, wellness and serious disease.</p> <p>Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health http://www.streetinsider.com/Globe+Newswire/Join+Genetic+Technology%E2%80%99s+Exclusive+Live+Investor+Webinar+and+Q%26amp%3BA+Session+on+August+15/23577580.html Fri, 09 Aug 2024 08:00:00 -0400 A.09642568 GENE GTG O.00709493 O.20371933 http://www.streetinsider.com/Corporate+News/Genetic+Technologies+%28GENE%29+Announces+Appointment+of+Chief+Financial+Officer+%26+Company+Secretary/23467157.html <p>Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and serious disease, is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary.</p><p> </p><p>Mark is a globally experienced ASX and Nasdaq listed CFO and company secretary with more than 25 years’ experience operating across life sciences, technology and consumer segments that include senior finance leadership roles with major ASX listed companies including Cochlear Limited, Aristocrat Leisure Limited, Coca-Cola Amatil Limited and Goodman Fielder Limited. More recently, in roles as an executive, interim or non-executive http://www.streetinsider.com/Corporate+News/Genetic+Technologies+%28GENE%29+Announces+Appointment+of+Chief+Financial+Officer+%26+Company+Secretary/23467157.html Tue, 16 Jul 2024 08:03:51 -0400 GENE GTG